SCHOTT Pharma

SCHOTT Pharma AG & Co. KGaA is a leading provider of drug containment and delivery solutions, specializing in primary packaging for injectable pharmaceuticals. Headquartered in Mainz, Germany, and part of SCHOTT AG owned by the Carl Zeiss Foundation, the company designs science-based products such as prefillable glass and polymer syringes, cartridges, vials, ampoules, and innovative systems like SCHOTT iQ® Integribag to ensure medications are safe, reliable, and user-friendly worldwide. With approximately 4,700 employees from over 65 nations, SCHOTT Pharma operates 16 GMP-compliant manufacturing sites across Europe, North and South America, and Asia, alongside sales offices for efficient global service. The firm holds over 1,000 in-house patents, features a cutting-edge R&D center in Switzerland with around 130 dedicated specialists, and commits to sustainability, targeting climate neutrality by 2030. Serving major pharmaceutical hubs, SCHOTT Pharma plays a vital role in the healthcare sector by enabling secure drug delivery, supporting innovations in patient safety, and contributing to advancements in deep cold storage and ready-to-use vials. Its heritage in specialty glass and polymers underscores its position as an industry pioneer focused on human health.